Review Confirms MSC Therapy Is Safe and May Improve Outcomes in MS

Published on Multiple Sclerosis News Today

A systematic review published in Cureus highlights that mesenchymal stem cell (MSC) therapy is safe, well tolerated, and may improve disability, reduce inflammation, and promote nerve repair in people with multiple sclerosis. Across eight studies involving 157 participants, MSC treatments lowered markers of nerve damage, boosted neuroprotective factors, and restored immune balance by enhancing regulatory T-cell activity. While results are encouraging, researchers emphasize the need for standardized protocols and larger clinical trials to fully validate MSC therapy in MS care.

Read the full article on Multiple Sclerosis News Today:

👉 Mesenchymal stem cell therapy shows potential: Study review

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full detail, refer to the original article via the provided link.